251 related articles for article (PubMed ID: 12686372)
1. Selective microglial activation in the rat rotenone model of Parkinson's disease.
Sherer TB; Betarbet R; Kim JH; Greenamyre JT
Neurosci Lett; 2003 May; 341(2):87-90. PubMed ID: 12686372
[TBL] [Abstract][Full Text] [Related]
2. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.
Cicchetti F; Brownell AL; Williams K; Chen YI; Livni E; Isacson O
Eur J Neurosci; 2002 Mar; 15(6):991-8. PubMed ID: 11918659
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
Sherer TB; Kim JH; Betarbet R; Greenamyre JT
Exp Neurol; 2003 Jan; 179(1):9-16. PubMed ID: 12504863
[TBL] [Abstract][Full Text] [Related]
5. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.
Caboni P; Sherer TB; Zhang N; Taylor G; Na HM; Greenamyre JT; Casida JE
Chem Res Toxicol; 2004 Nov; 17(11):1540-8. PubMed ID: 15540952
[TBL] [Abstract][Full Text] [Related]
6. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine.
Rodrigues RW; Gomide VC; Chadi G
Int J Neurosci; 2001 Jul; 109(1-2):91-126. PubMed ID: 11699344
[TBL] [Abstract][Full Text] [Related]
7. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA expression in the aged manganese-treated rats.
Tomás-Camardiel M; Herrera AJ; Venero JL; Cruz Sánchez-Hidalgo M; Cano J; Machado A
Brain Res Mol Brain Res; 2002 Jun; 103(1-2):116-29. PubMed ID: 12106697
[TBL] [Abstract][Full Text] [Related]
9. Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson's Disease Incidence.
De Miranda BR; Fazzari M; Rocha EM; Castro S; Greenamyre JT
Toxicol Sci; 2019 Jul; 170(1):133-143. PubMed ID: 30907971
[TBL] [Abstract][Full Text] [Related]
10. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.
Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH
Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208
[TBL] [Abstract][Full Text] [Related]
11. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
[TBL] [Abstract][Full Text] [Related]
12. Glial reaction to volkensin-induced selective degeneration of central neurons.
Cevolani D; Bentivoglio M; Strocchi P
Brain Res Bull; 2001 Mar; 54(4):353-61. PubMed ID: 11306186
[TBL] [Abstract][Full Text] [Related]
13. Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine.
Rodrigues RW; Gomide VC; Chadi G
Int J Neurosci; 2004 Feb; 114(2):197-216. PubMed ID: 14702208
[TBL] [Abstract][Full Text] [Related]
14. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine.
Sarkar S; Gough B; Raymick J; Beaudoin MA; Ali SF; Virmani A; Binienda ZK
Neurosci Lett; 2015 Oct; 606():53-9. PubMed ID: 26321151
[TBL] [Abstract][Full Text] [Related]
15. Microglial activation and tyrosine hydroxylase immunoreactivity in the substantia nigral region following transient focal ischemia in rats.
Huh Y; Jung JW; Park C; Ryu JR; Shin CY; Kim WK; Ryu JH
Neurosci Lett; 2003 Sep; 349(1):63-7. PubMed ID: 12946587
[TBL] [Abstract][Full Text] [Related]
16. Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia.
Ryu JK; Shin WH; Kim J; Joe EH; Lee YB; Cho KG; Oh YJ; Kim SU; Jin BK
Glia; 2002 Apr; 38(1):15-23. PubMed ID: 11921200
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
[TBL] [Abstract][Full Text] [Related]
18. Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging.
Phinney AL; Andringa G; Bol JG; Wolters ECh; van Muiswinkel FL; van Dam AM; Drukarch B
Parkinsonism Relat Disord; 2006 May; 12(4):228-38. PubMed ID: 16488175
[TBL] [Abstract][Full Text] [Related]
19. Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment.
Chuang JI; Chen ST; Chang YH; Jen LS
J Chem Neuroanat; 2001 May; 21(3):215-23. PubMed ID: 11382533
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.
Muñoz AM; Rey P; Soto-Otero R; Guerra MJ; Labandeira-Garcia JL
J Neurosci Res; 2004 May; 76(4):551-62. PubMed ID: 15114627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
